Cholesterol-lowering effects of probiotics and prebiotics: A review of in Vivo and in Vitro Findings

International Journal of Molecular Sciences

Volumn 11, Issue 6, 2010, Pages 2499-2522

  Ooi, Lay Gaik ^a   Liong, Min Tze ^a  

^a Universiti Sains Malaysia   (Malaysia)

Author keywords

Hypocholesterolemic; Mechanisms; Prebiotics; Probiotics; Safety

Indexed keywords

BETA CYCLODEXTRIN; CAUSIDO; FRUCTOSE OLIGOSACCHARIDE; GAIO; GALACTOSE OLIGOSACCHARIDE; INULIN; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; YOGHURT;

ARTHRITIS; AUTOIMMUNE DISEASE; BACTEREMIA; BIFIDOBACTERIUM LONGUM; BLOATING; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; ENDOCARDITIS; FEVER; FLATULENCE; GASTROINTESTINAL SYMPTOM; HEPATOBILIARY DISEASE; HUMAN; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS FERMENTUM; MUCOSA INFLAMMATION; NONHUMAN; REVIEW; SEPTICEMIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULITIS;

HYPOCHOLESTEROLEMIC; MECHANISMS; PREBIOTICS; PROBIOTICS; SAFETY;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPID METABOLISM; LIPIDS; PREBIOTICS; PROBIOTICS;

EID: 77954803814     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11062499     Document Type: Review

References (113)

1. WHO. Cardiovascular Disease; Fact sheet N°317, Geneva, Switzerland, September, 2009. Available at: http://www.who.int/mediacentre/factsheets/fs317/en/print.html (accessed on 19 May 2010).
2. Yusuf, S.; Hawken, S.; Ounpuu, S.; Dans, T.; Avezum, A.; Lanas, F.; McQueen, M.; Budaj, A.; Pais, P.; Varigo, J.; Lisheng, A. Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (The INTERHEART Study): Case-Control Study. Lancet 2004, 364, 937-952.
3. WHO. Diet, Nutrition and Prevention of Chronic Diseases; Report of a Joint WHO/FAO Expert Consultation, Geneva, Switzerland, 2003.
4. FAO, WHO. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria; Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, Cordoba, Argentina, 1-4 October, 2001.
5. Roberfroid, M. Prebiotics: The Concept Revisited. J. Nutr. 2007, 137, 830-837.
6. Galdeano, C.M.; de Le Blanc, A.; de M.; Vinderola, G.; Bonet, M.E.B.; Perdigón, G. Proposed Model: Mechanisms of Immunomodulation Induced by Probiotic Bacteria. Clin. Vaccine Immunol. 2007, 14, 485-492.
7. Yeo, S.K.; Liong, M.T. Angiotensin I-Converting Enzyme Inhibitory Activity and Bioconversion of Isoflavones by Probiotics in Soymilk Supplemented with Prebiotics. Int. J. Food Sci. Nutr. 2010, 61, 161-181.
8. Hirayama, K.; Rafter, J. The Role Of Probiotic Bacteria in Cancer Prevention. Microbes. Infect. 2000, 2, 681-686.
9. Songisepp, E.; Kulisaar, T.; Hütt, P.; Elias, P.; Brilene, T.; Zilmer, M.; Mikelsaar, M. A New Probiotic Cheese with Antioxidative and Antimicrobial. J. Dairy Sci. 2004, 87, 2017-2023.
10. Weston, S.; Halbert, A.; Richmond, P.; Prescott, S.L. Effects of Probiotics on Topic Dermatitis: A Randomised Controlled Trial. Arch. Dis. Child. 2005, 90, 892-897.
11. Scholz-Ahrens, K.E.; Ade, P.; Marten, B.; Weber, P.; Timm, W.; Asil, Y.; Glüer, C.-C.; Schrezenmeir, J. Prebiotics, Probiotics and Synbiotics Affect Mineral Absorption, Bone Mineral Content and Bone Structure. J. Nutr. 2007, 137, 838-846.
12. Baharav, E.; Mor, F.; Halpern, M.; Weinberger, A. Lactobacillus GG Bacteria Ameliorate Arthritis in Lewis Rats. J. Nutr. 2004, 134, 1964-1969.
13. Ouwehand, A.C. Antiallergic Effects of Probiotics. J. Nutr. 2007,137, 794-797.
14. Falagas, M.E.; Betsi, G.I.; Athanasiou, S. Probiotics for Prevention of Recurrent Vulvovaginal Candidiasis: A Review. J. Antimicrob. Chemother. 2006, 58, 266-272.
15. Pereira, D.I.A.; Gibson, G.R. Effects of Consumption of Probiotics and Prebiotics on Serum Lipid Levels in Human. Crit. Rev. Biochem. Mol. Biol. 2002, 37, 259-281.
16. Gibson, G.R.; Fuller, R. Aspects of in Vitro and in Vivo Research Approaches Directed Toward Identifying Probiotics and Prebiotics for Human Use. J. Nutr. 2000, 130, 391S-395S.
17. Cummings, J.H.; Macfarlane, G.T.; Englyst, H.N. Prebiotic Digestion and Fermentation. Am. J. Clin. Nutr. 2001, 73, 415-420.
18. Bielecka, M.; Biedrzycka, E.; Majkowska, A. Selection of Probiotics and Prebiotics for Synbiotic and Confirmation of Their in Vivo Effectiveness. Food Res. Int. 2002, 35, 139-144.
19. Schley, P.D.; Field, C.J. The Immune-Enhancing Effects of Dietary Fiber and Prebiotics. Br. J. Nutr. 2002, 87, 221-230.
20. Klinder, A.; Forster, A.; Caderni, G.; Femia, A.P.; Pool-Zobel, B.L. Fecal Water Genotoxicity is Predictive of Tumor-Preventive Activities by Inulin-Like Oligofructoses, Probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis) and Their Synbiotic Combination. Nutr. Cancer 2004, 49, 144-155.
21. Scholz-Ahrens, K.E.; Acil, Y.; Schrezenmeir, J. Effect of Oligofructose or Dietary Calcium on Repeated Calcium and Phosphorus Balances, Bone Mineralization and Trabecular Structure in Ovariectomized Rats. Br. J. Nutr. 2002, 88, 365-377.
22. Cummings, J.H.; Macfarlane, G. Gastrointestinal Effects of Prebiotics. Br. J. Nutr. 2002, 87, 145-151.
23. Topping, D.L.; Clifton, P.M. Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides. Physiol. Rev. 2001, 81, 1031-1064.
24. Hinnebusch, B.F.; Meng, S.-F.; Wu, J.T.; Archer, S.Y.; Hodin, R.A. The Effects of Short-Chain Fatty Acids on Human Colon Cancer Cell Phenotype Are Associated with Histone Hyperacetylation. J. Nutr. 2002,132, 1012-1017.
25. Dewailly, É.; Blanchet, C.; Gingras, S.; Lemieux, S.; Sauvé, L.; Bergeron, J.; Holub, B.J. Relations Between N-3 Fatty Acid Status and Cardiovascular Disease Risk Factors Among Quebecers. Am. J. Clin. Nutr. 2001, 74, 603-611.
26. Wolever, T.M.S.; Schrade, K.B.; Vogt, J.A.; Tsihlias, E.B.; McBurney, M.I. Do Colonic Short-Chain Fatty Acids Contribute to the Long-Term Adaptation of Blood Lipids in Subjects with Type 2 Diabetes Consuming a High-Fiber Diet? Am. J. Clin. Nutr. 2002, 75, 1023-1030.
27. Lambert, J.M.; Bongers, R.S.; de Vos, W.M.; Kleerebezem, M. Functional Analysis of Four Bile Salt Hydrolase and Penicillin Acylase Family Members in Lactobacillus plantarum WCFS1. Appl. Environ. Microbiol. 2008, 74, 4719-4726.
28. Pereira, D.I.A.; Gibson, G.R. Cholesterol Assimilation by Lactic Acid Bacteria and Bifidobacteria Isolated from the Human Gut. Appl. Environ. Microbiol. 2002, 68, 4689-4693.
29. Liong, M.T.; Shah, N.P. Effects of A Lactobacillus casei Synbiotic on Serum Lipoprotein, Intestinal Microflora, and Organic Acids in Rats. J. Dairy Sci. 2006, 89, 1390-1399.
30. Liong, M.T.; Shah, N.P. Acid and Bile Tolerance and Cholesterol Removal Ability of Lactobacilli Strains. J. Dairy Sci. 2005, 88, 55-66.
31. Lye, H.S.; Rusul, G.; Liong, M.T. Mechanisms of Cholesterol Removal by Lactoballi Under Conditions That Mimic the Human Gastrointestinal Tract. Int. Dairy J. 2010, 20, 169-175.
32. Lye, H.S.; Rusul, G.; Liong, M.T. Removal of Cholesterol by Lactobacilli via Incorporation of and Conversion to Coprostanol. J. Dairy Sci. 2010, 93, 1383-1392.
33. De Preter, V.; Vanhoutte, T.; Huys, G.; Swings, J.; De Vuyst, L.; Rutgeerts, P.; Verbeke, K. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and Oligofructose-Enriched Inulin on Colonic Nitrogen-Protein Metabolism in Healthy Humans. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, 358-368.
34. Peret-Filho, L.A.; Penna, F.J.; Bambirra, E.A.; Nicoli, J.R. Dose Effect of Oral Saccharomyces boulardii Treatments on Morbidity and Mortality in Immunosuppressed Mice. J. Med. Microbiol. 1998, 47, 111-116.
35. Land, M.H.; Rouster-Stevens, K.; Woods, C.R.; Cannon, M.L.; Cnota, J.; Shetty, A.K. Lactobacillus Sepsis Associated with Probiotic Therapy. Pediatrics 2005, 115, 178-181.
36. Huys, G.; D'Haene, K.; Swings, J. Genetic Basis of Tetracycline and Minocycline Resistance in Potentially Probiotic Lactobacillus plantarum Strain CCUG 43738. Antimicrob. Agents Chemother. 2006, 50, 1550-1551.
37. Shinnick, F.L.; Longacre, M.J.; Ink, S.L.; Maelett, J.A. Oat Fiber: Composition Versus Physiological Function in Rats. J. Nutr. 1988, 118, 144-151.
38. Gallaher, C.M.; Munion, J.; Hesslink, R.; Wise, J.; Gallaher, D.D. Cholesterol Reduction by Glucomannan and Chitosan is Mediated by Changes in Cholesterol Absorption and Bile Acid and Fat Excretion Iin Rats. J. Nutr. 2000, 130, 2753-2759.
39. Lichtman, A.H.; Clinton, S.K.; Iiyama, K.; Connelly, P.W.; Libby, P.; Cybulsky, M.I. Hyperlipidemia and Atherosclerotic Lesion Development in LDL Receptor-Deficient Mice Fed Defined Semipurified Diets with and without Cholate. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1938-1944.
40. Lin, Y.-G.; Meijer, G.W.; Vermeer, M.A.; Trautwein, E.A. Soy Protein Enhances the Cholesterol-Lowering Effect of Plant Sterol Esters in Cholesterol-Fed Hamsters. J. Nutr. 2004, 134, 143-148.
41. Madsen, C.S.; Janovitz, E.; Zhang, R.; Nguyen-Tran, V.; Ryan, C.S.; Yin, X.-H.; Monshizadegan, H.; Chang, M.; D'Arienzo, C.; Scheer, S.; Setters, R.; Search, D.; Chen, X.; Zhuang, S.-B.; Kunselman, L.; Peters, A.; Harrity, T.; Apedo, A.; Huang, C.; Cuff, C.A.; Kowala, M.C.; Blanar, M.A.; Sun, C.-Q.; Robl, J.A.; Stein, P.D. The Guinea Pig as a Preclinical Model for Demonstrating the Efficacy and Safety of Statins. J. Pharmacol. Exp. Ther. 2007, 324, 576-586.
42. Patterson, J.K.; Lei, X.G.; Miller, D.D. The Pig as an Experimental Model for Elucidating the Mechanisms Governing Dietary Influence on Mineral Absorption. Exp. Biol. Med. 2008, 233, 651-664.
43. Fernandez, M.L.; Roy, S.; Vergara-Jimenez, M. Resistant Starch and Cholestyramine Have Distinct Effects on Hepatic Cholesterol Metabolism in Guinea Pigs Fed a Hypercholesterolemic Diet. Nutr. Res. 2000, 20, 837-849.
44. Nguyen, T.D.T.; Kang, J.H.; Lee, M.S. Characterization of Lactobacillus plantarum PH04, a Potential Probiotic Bacterium with Cholesterol-Lowering Effects. Int. J. Food Microbiol. 2007, 113, 358-361.
45. Abd El-Gawad, I.A.; El-Sayed, E.M.; Hafez, S.A.; El-Zeini, H.M.; Saleh, F.A. The Hypocholesterolaemic Effect of Milk Yoghurt and Soy-Yoghurt Containing Bifidobacteria in Rats Fed on a Cholesterol-Enriched Diet. Int. Dairy J. 2005, 15, 37-44.
46. Fukushima, M.; Yamada, A.; Endo, T.; Nakano, M. Effects of A Mixture of Organisms, Lactobacillus acidophilus or Streptococcus faecalis on D6-Desaturase Activity in The Livers of Rats Fed A Fat- and Cholesterol-Enriched Diet. Nutrrients 1999, 15, 373-378.
47. Anderson, J.W.; Gilliland, S.E. Effect of Fermented Milk (Yogurt) Containing Lactobacillus acidophilus L1 on Serum Cholesterol in Hypercholesterolemic Humans. J. Am. Coll. Nutr. 1999, 18, 43-50.
48. Xiao, J.Z.; Kondo, S.; Takahashi, N.; Miyaji, K.; Oshida, K.; Hiramatsu, A.; Iwatsuki, K.; Kokubo, S.; Hosono, A. Effects of Milk Products Fermented by Bifidobacterium longum on Blood Lipids in Rats and Healthy Adult Male Volunteers. J. Dairy Sci. 2003, 86, 2452-2461.
49. Causey, J.L.; Feirtag, J.M.; Gallaher, D.D.; Tungland, B.C.; Slavin, J.L. Effects of Dietary Inulin on Serum Lipids, Blood Glucose and the Gastrointestinal Environment in Hypercholesterolemic Men. Nutr. Res. 2000, 20, 191-201.
50. Letexier, D.; Diraison, F.; Beylot, M. Addition of Inulin to a Moderately High-Carbohydrate Diet Reduces Hepatic Lipogenesis and Plasma Triacylglycerol Concentrations in Humans. Am. J. Clin. Nutr. 2003, 77, 559-564.
51. Brighenti, F.; Casiraghi, M.C.; Canzi, E.; Ferrari, A. Effect of Consumption of a Ready-to-Eat Breakfast Cereal Containing Inulin on the Intestinal Milieu and Blood Lipids in Healthy Male Volunteers. Eur. J. Clin. Nutr. 1999, 53, 726-733.
52. Mortensen, A.; Poulsen, M.; Frandsen, H. Effect of Long-Chained Fructan Raftilose ® HP on Blood Lipids and Spontaneous Atherosclerosis in Low Density Receptor Knockout Mice. Nutr. Res. 2002, 22, 473-480.
53. Gibson, G.R.; Probert, H.M.; Van Loo, J.A.E.; Roberfroid, M.B. Dietary Modulation of the Human Colonic Microbiota: Updating the Concept of Prebiotics. Nutr. Res. Rev. 2004, 17, 257-259.
54. Wang, S.J.; Yu, J.L.; Liu, H.Y.; Chen, W.P. Characterisation and Preliminary Lipid-Lowering Evaluation of Starch from Chinese Yam. Food Chem. 2008, 108, 176-181.
55. Favier, M.-L.; Moundras, C.; Demigné, C.; Rémésy, C. Fermentable Carbohydrates Exert a More Potent Cholesterol-Lowering Effect than Cholestyramine. Biochim. Biophys. Acta 1995, 1258, 115-121.
56. Liong, M.T.; Dunshea, F.R.; Shah, N.P. Effects of A Synbiotic Containing Lactobacillus acidophilus ATCC 4962 on Plasma Lipid Profiles and Morphology of Erythrocytes in Hypercholesterolemic Pigs on High- and Low-Fat Diets. Br. J. Nutr. 2007, 98, 736-744.
57. Kießling, G.; Schneider, J.; Jahreis, G. Long-Term Consumption of Fermented Dairy Products over 6 Months Increases HDL Cholesterol. Eur. J. Clin. Nutr. 2002, 56, 843-849.
58. Schaafsma, G.; Meuling, W.J.A.; van Dokkum, W.; Bouley, C. Effects of A Milk Product, Fermented by Lactobacillus acidophilus and with Fructo-Oligosaccharides Added, on Blood Lipids in Male Volunteers. Eur. J. Clin. Nutr. 1998, 52, 436-440.
59. Hatakka, K.; Mutanen, M.; Holma, R.; Saxelin, M.; Korpela, R. Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS Administered in Capsules Is Ineffective in Lowering Serum Lipids. J. Am. Coll. Nutr. 2008, 27, 441-447.
60. Simons, L.A.; Amansec, S.G.; Conway, P. Effect of Lactobacillus fermentum on Serum Lipids in Subjects with Elevated Serum Cholesterol. Nutr. Metabolism Cardiovas. Dis. 2006, 16, 531-535.
61. Lewis, S.J.; Burmeister, S.A Double-Blind Placebo-Controlled Study of the Effects of Lactobacillus acidophilus on Plasma Lipids. Eur. J. Clin. Nutr. 2005, 59, 776-780.
62. Tarpila, S.; Aro, A.; Salminen, I.; Tarpila, A.; Kleemola, P.; Akkila, J.; Adlercreutz, H. The Effect of Flaxseed Supplementation in Processed Foods on Serum Fatty Acids and Enterolactone. Eur. J. Clin. Nutr. 2002, 56, 157-165.
63. Luo, J.; Van Yperselle, M.; Rizkalla, S.W.; Rossi, F.; Bornet, F.R.J.; Slama, G. Chronic Consumption of Short-Chain Fructooligosaccharides Does Not Affect Basal Hepatic Glucose Production or Insulin Resistance in Type 2 Diabetics. J. Nutr. 2000, 130, 1572-1577.
64. Davidson, M.H.; Maki, K.C.; Synecki, C.; Toni, S.A.; Drennan, K.B. Effects of Dietary Inulin on Serum Lipids in Men and Women with Hypercholesterolemia. Nutr. Res. 1998, 18, 503-517.
65. Greany, K.A.; Bonorden, M.J.L.; Halmiton-Reeves, J.M.; McMullen, M.H.; Wangen, K.E.; Phipps, W.R.; Feirtag, J.; Thomas, W.; Kurzer, M.S. Probiotic Capsules Do Not Lower Plasma Lipid in Young Women and Men. Eur. J. Clin. Nutr. 2008, 62, 232-237.
66. Liong, M.T. Probiotics: A Critical Review of Their Potential Role as Antihypertensive, Immune Modulators, Hypocholesterolemics and Perimenopausal Treatments. Nutr. Rev. 2007, 65, 1-13.
67. Food and Agriculture Organization of the United Nations and World Health Organization. Probiotics in Food: Health and Nutritional Properties and Guidelines for Evaluation; Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, Cordoba, Argentina, 1-4 October 2001 [and] Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada, 30 April-1 May 2002.
68. Naruszewicz, M.; Johansson, M.-L.; Zapolska-Downar, D.; Bukowska, H. Effect of Lactobacillus plantarum 299v on Cardiovascular Disease Risk Factors in Smokers. Am. J. Clin. Nutr. 2002, 76, 1249-1255.
69. Lubbadeh, W.; Haddadin, M.S.Y.; Al-Tamimi, M.A.; Robinson, R.K. Effect on the Cholesterol Content of Fresh Lamb of supplementing the Feed of Awassi Ewes and Lambs with Lactobacillus acidophilus. Meat Sci. 1999, 52, 381-385.
70. Ha, C.G.; Cho, J.K.; Lee, C.H.; Chai, Y.G.; Ha, Y.A.; Shin, S.H. Cholesterol Lowering Effect of Lactobacillus plantarum Isolated from Human Feces. J. Mol. Microbiol. Biotechnol. 2006, 16, 1201-1209.
71. Greany, K.A.; Nettleton, J.A.; Wangen, K.E.; Thomas, W.; Kurzer, M.S. Probiotic Consumption Does Not Enhance the Cholesterol-Lowering Effect of Soy in Postmenopausal Women. J. Nutr. 2004, 134, 3277-3283.
72. Jeun, J.; Kim, S.-Y.; Cho, S.-Y.; Jun, H.-J.; Park, H.-J.; Seo, J.-G.; Chung, M.-J.; Lee, S.-J. Hypocholesterolemic Effects of Lactobacillus plantarum KCTC3928 by Increased Bile Acid Excretion in C57BL/6 Mice. Nutrition 2010, 26, 321-330.
73. Bertolami, M.C.; Faludi, A.A.; Batlouni, M. Evaluation of the Effects of a New Fermented Milk Product (Gaio) on Primary Hypercholesterolemia. Eur. J. Clin. Nutr. 1999, 53, 97-101.
74. FAO Technical Meeting on Prebiotics: Food Quality and Standards Service (AGNS). Food and Agriculture Organization of the United Nations (FAO): Rome, Italy, 15-16 September, 2007.
75. Vogt, J.A.; Ishii-Schrade, K.B.; Pencharz, P.B.; Jones, P.J.H.; Wolever, T.M.S. L-Rhamnose and Lactulose Decrease Serum Triacylglycerols and Their Rates of Synthesis, But Do Not Affect Serum Cholesterol Concentrations in Men. J. Nutr. 2006, 136, 2160-2166.
76. Robinson, R.R.; Feirtag, J.; Slavin, J.L. Effects of Dietary Arabinogalactan on Gastrointestinal and Blood Parameters in Healthy Human Subjects. J. Am. Coll. Nutr. 2001, 20, 279-285.
77. Trautwein, E.A.; Rieckhoff, D.; Erbersdobler, H.F. Dietary Inulin Lowers Plasma Cholesterol and Triacylglycerol and Alters Biliary Bile Acid Profile in Hamsters. J. Nutr. 1998, 128, 1937-1943.
78. Li, X.J.; Piao, X.S.; Kim, S.W.; Liu, P.; Wang, L.; Shen, Y.B.; Jung, S.C.; Lee, H.S. Effects of Chito-Oligosaccharide Supplementation on Performance, Nutrient Digestibility, and Serum Composition in Broiler Chickens. Poultry Sci. 2007, 86, 1107-1114.
79. Hsu, C.K.; Liao, J.W.; Chung, Y.C.; Hsieh, C.P.; Chan, Y.C. Xylooligosaccharides and Fructooligosaccharides Affect the Intestinal Microbiota and Precancerous Colonic Lesion Development in Rats. J. Nutr. 2004, 134, 1523-1528.
80. Chen, H.; Liu, L.-J.; Zhu, J.-J.; Xu, B.; Li, R. Effect of Soybean Oligosaccharides on Blood Lipid, Glucose Levels and Antioxidant Enzymes Activity in High Fat Rats. Food Chem. 2010, 119, 1633-1636.
81. Alles, M.S.; de Roos, N.M.; Bakx, J.C.; van de Lisdonk, E.; Zock, P.L.; Hautvast, J.G.A.J. Consumption of Fructooligosaccharides Does Not Favorably Affect Blood Glucose and Serum Lipid Concentrations in Patients with Type 2 Diabetes. Am. J. Clin. Nutr. 1999, 69, 64-69.
82. Vulevic, J.; Drakoularakou, A.; Yaqoob, P.; Tzortzis, G.; Gibson, G.R. Modulation of the Fecal Microflora Profile and Immune Function by a Novel Trans-Galactooligosaccharide Mixture (BGOS) in Healthy Elderly Volunteers. Am. J. Clin. Nutr. 2008, 88, 1438-1446.
83. Liong, M.T.; Shah, N.P. Optimization of Cholesterol Removal by Probiotics in the Presence of Prebiotics by Using a Response Surface Method. Appl. Environ. Microbiol. 2005, 71, 1745-1753.
84. Zhang, F.; Hang, X.; Fan, X.; Li, G.; Yang, H. Selection and Optimization Procedure of Synbiotic for Cholesterol Removal. Anaerobe 2007, 13, 185-192.
85. Begley, M.; Hill, C.; Gahan, C.G.M. Bile Salt Hydrolase Activity in Probiotics. Appl. Environ. Microbiol. 2006, 72, 1729-1738.
86. Jones, M.L.; Chen, H.; Ouyang, W.; Metz, T.; Prakash, S. Microencapsulated Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol. J. Biomed. Biotechnol. 2004, 1, 61-69.
87. Usman, H.A. Bile Tolerance, Taurocholate Deconjugation, and Binding of Cholesterol by Lactobacillus gasseri Strains. J. Dairy Sci. 1999, 82, 243-248.
88. Kimoto, H.; Ohmomo, S.; Okamoto, T. Cholesterol Removal from Media by Lactococci. J. Dairy Sci. 2002, 85, 3182-3188.
89. Chiang, Y.R.; Ismail, W.; Heintz, D.; Schaeffer, C.; van Dorsselaer, A.; Fuchs, G. Study of Anoxic and Oxic Cholesterol Metabolism by Sterolibacterium denitrificans. J. Bacteriol. 2008, 190, 905-914.
90. Arjmandi, B.H.; Craig, J.; Nathani, S.; Reeves, R.D. Soluble Dietary Fiber and Cholesterol Influence in Vivo Hepatic and Intestinal Cholesterol Biosynthesis in Rats. J. Nutr. 1992, 122, 1559-1565.
91. Kim, M.-H.; Shin, H.K. The Water-Soluble Extract Of Chicory Influences Serum and Liver Lipid Concentrations, Cecal Short-Chain Fatty Acid Concentrations and Fecal Lipid Excretion in Rats. J. Nutr. 1998, 128, 1731-1736.
92. Dikeman, C.L.; Murphy, M.R.; Fahey, G.C. Dietary Fibers Affect Viscosity of Solutions and Simulated Human Gastric and Small Intestinal Digesta. J. Nutr. 2006, 136, 913-919.
93. Rossi, M.; Corradini, C.; Amaretti, A.; Nicolini, M.; Pompei, A.; Zanoni, S.; Matteuzzi, D. Fermentation of Fructooligosaccharides and Inulin By Bifidobacteria: A Comparative Study of Pure and Fecal Cultures. Appl. Environ. Microbiol. 2005, 71, 6150-6158.
94. Olano, A.; Chua, J.; Schroeder, S.; Minari, A.; Salvia, M.L.; Hall, G. Weissella confusa (Basonym: Lactobacillus confusus) Bacteremia: A Case Report. J. Clin. Microbiol. 2001, 39, 1604-1607.
95. d'Escrivan, T.; Meybeck, A.; Legout, L.; Georges, H.; Senneville, E. Severe Sepsis Due to Lactobacillus helvetica Bacteremia. Med. Maladies Infect. 2003, 33, 356-357.
96. Chazan, B.; Raz, R.; Shental, Y.; Sprecher, H.; Colodner, R. Bacteremia and Pyelonephritis Caused by Lactobacillus jensenii in a Patient with Urolithiasis. Isr. Med. Assoc. J. 2008, 10, 164-165.
97. Zé-Zé, L.; Tenreiro, R.; Duarte, A.; Salgado, M.J.; Melo-Cristino, J.; Lito, L.; Carmo, M.M.; Felisberto, S.; Carmo, G. Case of Aortic Endocarditis Caused by Lactobacillus casei. J. Med. Microbiol. 2004, 53, 451-453.
98. Rautio, M.; Jousimies-Somer, H.; Kauma, H.; Pietarinen, I.; Saxelin, M.; Tynkkynen, S.; Koskela, M. Liver Abscess Due to a Lactobacillus rhamnosus Indistinguishable from L. rhamnosus Strain GG. Clin. Infect. Dis. 1999, 28, 1159-1160.
99. Ruseler-van Ebmden, J.H.G.; van Lieshout, L.; Gosselink, M.; Marteau, P. Inability of Lactobacillus casei Strain GG, Lactobacillus acidophilus, and Bifidobacterium bifidum to Degrade Intestinal Mucosa Glycoproteins; Clearing the Way for Mucosa-Protective Therapy. Scand. J. Gastroenterol. 1995, 30, 675-680.
100. Abe, F.; Muto, M.; Yaeshima, T.; Iwatsuki, K.; Aihara, H.; Ohashi, Y.; Fujisawa, T. Safety Evaluation of Probiotic Bifidobacteria by Analysis of Mucin Degradation Activity and Translocation Ability. Anaerobe 2010, 16, 131-136.
101. Tan, K. P.; Yang, M.; Ito, S. Activation of Nuclear Factor (Erythroid-2 Like) Factor 2 by Toxic Bile Acids Provokes Adaptive Defense Responses to Enhance Cell Survival at the Emergence of Oxidative Stress. Mol. Pharmacol. 2007, 72, 1380-1390.
102. Miettinen, M.; Vuopio-Varkila, J.; Varkila, K. Production of Human Necrosis Factor Alpha, Interleukin 6, and Interleukin 10 Is Induced by Lactic Acid Bacteria. Infect. Immun. 1996, 64, 5403-5405.
103. Shimizu, N.; Kamezaki, F.; Shigematsu, S. Tracking of Microinjected DNA in Live Cells Reveals the Intracellular Behavior and Elimination of Extrachromosomal Genetic Material. Nucleic Acids Res. 2005, 33, 6296-6307.
104. Deichelbohrer, I.; Alonso, J.C.; Lüder, G.; Trautner, T.A. Plasmid Transduction by Bacillus subtilis Bacteriophage SPP1: Effects of DNA Homology between Plasmid and Bacteriophage. J. Bacteriol. 1985, 162, 1238-1243.
105. Merryweather, A.; Barth, P.T.; Wilkins, B.M. Role and Specificity of Plasmid RP4-Encoded DNA Primase in Bacterial Conjugation. J. Bacteriol. 1986, 167, 12-17.
106. Prágai, Z.; Holczinger, A.; Sík, T. Transformation of Bacillus licheniformis Protoplasts by Plasmid DNA. Microbiology 1994, 140, 305-310.
107. Liong, M.T.; Yeo, S.K.; Kuan, C.Y.; Fung, W.Y.; Ewe, J.A. Antibiotic Resistance and Probiotics: Roles, Mechanisms and Evidence. In Antibiotic Resistance: Causes and Risk Factors; Bonilla, A.R., Muniz, K.P., Eds.; Nova Science Publishers, Inc.: New York, NY, USA, 2009; pp. 5-38.
108. D'Aimmo, M.R.; Modesto, M.; Biavati, B. Antibiotic Resistance of Lactic Acid Bacteria and Bifidobacterium spp. Isolated from Dairy and Pharmaceutical Products. Int. J. Food Microbiol. 2007, 115, 35-42.
109. Hummel, A.S.; Hertel, C.; Holzapfel, W.H.; Franz, C.M.A.P. Antibiotic Resistances of Starter and Probiotic Strains of Lactic Acid Bacteria. Appl. Environ. Microbiol. 2007, 73, 730-739.
110. Coussement, P.A.A. Inulin and Oligofructose: Safe Intakes and Legal Status. J. Nutr. 1999, 129, 1412-1417.
111. Williams, C.M. Effects of Inulin on Lipid Parameters in Humans. J. Nutr. 1999, 129, 1471-1473.
112. Bruggencate, S.J.M.T.; Bovee-Oudenhoven, I.M.J.; Lettink-Wissink, M.L.G.; van der Meer, R. Dietary Fructooligosaccharides Increase Intestinal Permeability in Rats. J. Nutr. 2005, 135, 837-842.
113. Bruggencate, S.J.M.T.; Bovee-Oudenhoven, I.M.J.; Lettink-Wissink, M.L. G; Katan, M.B.; van der Meer, R. Dietary Fructooligosaccharides Affect Intestinal Barrier Function in Healthy Men. J. Nutr. 2006, 136, 70-74.